PARIS — In a move to bolster its skin health activity, Nestlé said it is acquiring the rights to commercialize the aesthetic dermatology products Restylane, Perlane, Emervel, Dysport and Sculptra in the U.S. and Canada from Valeant Pharmaceuticals International for $1.4 billion in cash.
Nestlé said the U.S. and Canada together represent more than 50 percent of the global medical aesthetics market.
Issa Rae stopped by WWD's NYC headquarters to talk about season two of "Insecure," which premieres this Sunday on HBO. Click link in bio for all the details. #wwdeye (📷: @jgreenery; Styled by @mayteallende)
A Stella McCartney sketch of a custom dress made from protein-based silk in partnership with biotech lab Bolt Threads. The dress will be displayed at The Museum of Modern Art's upcoming design exhibition, "Items: Is Fashion Modern?"